EBV vaccination strategies are proposed which will be evaluated in severe combined immunodeficient mice engrafted with adult human immunocompetent cells (SCID-Adult Hu). One form of mouse-human chimera is generated by the inoculation of SCID mice with peripheral blood leukocytes from adult EBV negative donors. Another chimeric model is generated by the inoculation of bone marrow from healthy adult donors into neonatal or adult SCID mice. Both animal models support the engraftment of functional human B and T cells and with the provision of human hematopoietic factors to mice inoculated with human bone marrow, it has been shown that the murine microenvironment can support the engraftment of human stem cells which subsequently leads to a high level multi-lineage engraftment in the spleen, lymph node, peripheral blood and bone marrow. These recent advances in the transplantation of human immunocompetent cells into immunodeficient mice, and the ability of exogenous EBV to infect and transform human B cells residing in SCID mice provide a viable and unique opportunity to evaluate the efficacy of different EBV vaccination protocols. Each protocol will be tested in SCID-Adult Hu mice for the ability to induce immunity which protects the mice from EBV-induced disseminated lymphoproliferation. The first vaccination protocol to be tested focuses upon the use of a subunit preparation consisting of a truncated gp 350/220 protein. SCID-Adult Hu mice will be immunized with this viral envelope protein either in solution or covalently attached to a particulate carrier (liposomes or milk fat globules). A second protocol utilizes a transformation-defective EBV as the mutant immunogen. In the third vaccination protocol, SCID-Adult Hu mice are immunized with an autologous B-cell that has been transformed in vitro by EBV. In an effort to maximize the human lymphocyte response, the immunizing cells are also modified by gene transfer to produce and secrete human IL-2. In addition to testing the vaccination strategies, EBV mutants are being developed and assessed in vitro and in SCID-Adult Hu mice to investigate the significance of several EBV genes that lack known functions. The information obtained from these studies should contribute to the development of an attenuated live virus vaccine.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA057974-02
Application #
3202265
Study Section
Special Emphasis Panel (SRC (66))
Project Start
1992-08-01
Project End
1996-05-31
Budget Start
1993-06-01
Budget End
1994-05-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Caligiuri, M A; Strout, M P; Oberkircher, A R et al. (1997) The partial tandem duplication of ALL1 in acute myeloid leukemia with normal cytogenetics or trisomy 11 is restricted to one chromosome. Proc Natl Acad Sci U S A 94:3899-902
Caligiuri, M A; Strout, M P; Schichman, S A et al. (1996) Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res 56:1418-25
Egilmez, N K; Iwanuma, Y; Bankert, R B (1996) Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer. Biochem Biophys Res Commun 221:169-73
Diamond, M; Williams, S S; Kida, H et al. (1996) VH and VL gene complexes encoding an anti-spectrin antibody are defined by nucleotide sequencing of cDNA from a hybridoma generated from Hu-PBL-SCID mouse. Immunol Invest 25:291-305
Sakakibara, T; Chen, F A; Kida, H et al. (1996) Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts. Cancer Res 56:3743-6
Bumpers, H L; Alosco, T R; Wang, H Q et al. (1996) Consistent hepatic metastasis of human colorectal cancer in severe combined immunodeficient mice. J Surg Res 61:282-8
Williams, S S; Chen, F A; Kida, H et al. (1996) Engraftment of human tumor-infiltrating lymphocytes and the production of anti-tumor antibodies in SCID mice. J Immunol 156:1908-15
Falkenberg, S; Winter, D; Bankert, R B (1995) Transient dominance of the early primary immune response by a highly conserved B-cell clone that is distinguished by its lack of memory, high threshold of activation, and a high affinity. Cell Immunol 160:123-31
Chen, F A; Williams, S S; Fanslow, W C et al. (1995) Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand. J Immunol 155:2833-40
Carson, W E; Lindemann, M J; Baiocchi, R et al. (1995) The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 85:3577-85

Showing the most recent 10 out of 18 publications